Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

The Four Cornerstones of a Pharmacovigilance Organization

Posted on May 8th, 2017 by in Pharmacovigilance

For small organizations, building a PV department from the ground up can be an exercise of trial and error, frustrating and costly. Being in growth mode means that there is not much time to anticipate and plan, as multiple high priorities compete for attention. Continue reading “The Four Cornerstones of a Pharmacovigilance Organization” »

Making Pharmacovigilance a Company-Wide Responsibility

Posted on June 20th, 2016 by in Pharmacovigilance

The scope of pharmacovigilance has expanded. Regulatory agencies have placed new demands on how pharmaceutical companies are expected to ensure the safety of their products and manage benefit–risk. Continue reading “Making Pharmacovigilance a Company-Wide Responsibility” »

Pharmacovigilance events in different regions cover common concerns

Posted on January 7th, 2016 by in Pharmacovigilance

In December, Elsevier sponsored the 11th Annual Pharmacovigilance, Drug Safety and Risk Management conference in Brussels, Belgium and the 2nd Adverse Event Reporting and Safety Strategies Summit in Philadelphia, USA.  Continue reading “Pharmacovigilance events in different regions cover common concerns” »